Dr. Ho is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 1st St Sw
Rochester, MN 55905
Education & Training
Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 2014 - 2017
David Geffen School of Medicine at UCLAClass of 2013
Certifications & Licensure
MN State Medical License 2015 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- A First-in-Human, Phase 1 Dose-Escalation and Cohort Expansion Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of BJ-005 in Patients With Advanced Solid Tumor or Lymphoma Start of enrollment: 2021 Oct 20
Roles: Contact
Publications & Presentations
PubMed
- Management and Long-Term Outcomes of Patients With Hepatic Epithelioid Hemangioendothelioma.Tedy Sawma, Ahmer Sultan, Samer Abdulmoneim, Travis Grotz, Charles B Rosen
Journal of Surgical Oncology. 2024-10-01 - Tolerability and Outcomes for Treatment of Older Myxoid Liposarcoma Population.Reilly A Coombs, Judith Jebastin Thangaiah, Brittany L Siontis, Steven I Robinson, Scott H Okuno
Cancers. 2024-09-23 - Unplanned Excision of Synovial Sarcoma: Factors Associated with Recurrence and Survival.Samuel E Broida, Alexandra M Arguello, Mikaela H Sullivan, Steven I Robinson, Scott H Okuno
Cancers. 2024-09-14
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
